FIT Biotech enjoys significant benefits from recognised scientific advisors who assist the company in research and development. Members of the scientific advisory board are highly respected opinion leaders in vaccinology, HIV/AIDS research and gene therapy.
Many of them are also advisors to major vaccine and pharmaceutical companies, which directly benefits FIT Biotech in licensing and co-operation activities.
Dr. Richard A. Koup
Chief, Immunology Laboratory Vaccine Research Center, The National Institutes of Health (NIH), USA
Prof. Giuseppe Pantaleo
Professor of Medicine
Chief of the Laboratory of AIDS Immunopathogenesis at the Centre Hospitalier Universitaire Vaudois (CHUV), University of Lausanne
Dr. Roger Le Grand
Head of the Department of Immuno-Virology of the Institute of Emerging Diseases and Innovative Therapies at the “Commissariat à l’Energie Atomiqueet Energies Alternatives” (CEA), France
Prof. A. Stanley Plotkin
Emeritus Professor of the University of Pennsylvania
Executive Advisor to Sanofi Pasteur
Prof. Michael M. Lederman
Professor of Medicine at Case Western Reserve University, United States of America